Favorable Outcome After COVID-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic

Publication date: Available online 23 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Mahsa Ghajarzadeh, Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, Saeed Vaheb, Vahid Shaygannejad, Amir-Hadi Maghzi
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research